Histone demethylase KDM1A promotes hepatic steatosis and inflammation by increasing chromatin accessibility in NAFLD
Zifeng Yang,Siyao Zhang,Xiang Liu,Rui Shu,Wei Shi,Weiyi Qu,Dianyu Liu,Zhiwei Cai,Ye Wang,Xu Cheng,Yemao Liu,Xiao-Jing Zhang,Lan Bai,Hongliang Li,Zhi-Gang She
DOI: https://doi.org/10.1016/j.jlr.2024.100513
IF: 6.676
2024-01-31
Journal of Lipid Research
Abstract:Highlights • The expression of KDM1A is upregulated in the context of NAFLD • KDM1A exacerbate inflammation and lipid accumulation in hepatocytes and in mice. • KDM1A lead to the development of NAFLD via increasing chromatin accessibility. • The enzyme activity of KDM1A is crucial for the development of NAFLD. Nonalcoholic fatty liver disease (NAFLD) is the most prevalent chronic liver disease without specific FDA-approved drugs. Recent advances suggest that chromatin remodeling and epigenetic alteration contribute to the development of NAFLD. The functions of the corresponding molecular modulator in NAFLD, however, are still elusive. KDM1A, commonly known as LSD1 (lysine-specific histone demethylase 1), has been reported to increase glucose uptake in hepatocellular carcinoma. In addition, a recent study suggests that inhibition of KDM1A reduces lipid accumulation in primary brown adipocytes. We here investigated the role of KDM1A, one of the most important histone demethylases, in NAFLD. In this study, we observed a significant upregulation of KDM1A in NAFLD mice, monkeys, and humans compared to the control group. Based on these results, we further found that the KDM1A can exacerbate lipid accumulation and inflammation in hepatocytes and mice. Mechanistically, KDM1A exerted its effects by elevating chromatin accessibility, subsequently promoting the development of NAFLD. Furthermore, the mutation of KDM1A blunted its capability to promote the development of NAFLD. In summary, our study discovered that KDM1A exacerbates hepatic steatosis and inflammation in NAFLD via increasing chromatin accessibility, further indicating the importance of harnessing chromatin remodeling and epigenetic alteration in combating NAFLD. KDM1A might be considered as a potential therapeutic target in this regard.
biochemistry & molecular biology